BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29905011)

  • 1. Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
    Zhou C; Chen W; Sun J; Atyah M; Yin Y; Zhang W; Guo L; Ye Q; Dong Q; Shi Y; Ren N
    Cancer Med; 2018 Jul; 7(7):3031-3043. PubMed ID: 29905011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
    Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
    Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
    Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
    BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
    Liao R; Wei XF; Che P; Yin KL; Liu L
    Front Oncol; 2021; 11():755920. PubMed ID: 35127471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
    Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
    Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma.
    Chen W; Zhou C; Zhang W; Atyah M; Yin Y; Guo L; Tang W; Dong Q; Ye Q; Ren N
    J Cancer; 2018; 9(7):1239-1247. PubMed ID: 29675105
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection.
    Zhou C; Sun J; Zheng Z; Weng J; Atyah M; Zhou Q; Chen W; Zhang Y; Huang J; Yin Y; Mao H; Zhang Z; Yi Y; Ren N
    Ann Transl Med; 2020 Apr; 8(7):466. PubMed ID: 32395510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
    Fu YP; Yi Y; Cai XY; Sun J; Ni XC; He HW; Wang JX; Lu ZF; Huang JL; Cao Y; Zhou J; Fan J; Qiu SJ
    Br J Cancer; 2016 Mar; 114(7):767-76. PubMed ID: 27002937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy.
    Wang Y; Sun K; Shen J; Li B; Kuang M; Cao Q; Peng S
    Cancer Res Treat; 2019 Oct; 51(4):1464-1478. PubMed ID: 30913869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection.
    Jing CY; Fu YP; Zheng SS; Yi Y; Shen HJ; Huang JL; Xu X; Lin JJ; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Medicine (Baltimore); 2017 Mar; 96(11):e6140. PubMed ID: 28296727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
    Lee HL; Cheng HL; Liu YF; Chou MC; Yang SF; Chou YE
    PLoS One; 2017; 12(4):e0176141. PubMed ID: 28426730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
    Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
    Front Oncol; 2021; 11():742630. PubMed ID: 34745962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection.
    Zeng J; Zeng J; Wu Q; Lin K; Zeng J; Guo P; Zhou W; Liu J
    Ann Transl Med; 2020 Sep; 8(17):1061. PubMed ID: 33145280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
    Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
    Front Oncol; 2022; 12():946531. PubMed ID: 35936698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
    Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
    JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of WW domain-containing oxidoreductase and its clinical implication in endometrial adenocarcinoma patients with metabolic syndrome.
    Shen Y; Gao L; Jiang S; Liu J; Cheng W; Shou H
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):70-75. PubMed ID: 33629514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.